ESC 365 - Empagliflozin improves diastolic function in obese ZSF1 rats by restoring the cardiac mitochondrial respiratory capacity.

ESC Professional Premium Access

Empagliflozin improves diastolic function in obese ZSF1 rats by restoring the cardiac mitochondrial respiratory capacity.

Session: Heart failure with preserved ejection fraction: bench

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Speaker: Doctor A. Schauer (Dresden, DE)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Antje Schauer

Heart Centre Dresden - Dresden Technical University Hospital, Dresden (Germany)

0 follower

3 more presentations in this session

The SGLT2I Dapagliflozin reverses metabolic stress driving myocardial inflammation in a mouse model of heart failure with preserved ejection fraction: insights from single-cell RNA sequencing

Speaker: Doctor C. Panico (Rozzano, IT)

Diabetes and chronic kidney disease synergistically contribute to left ventricular diastolic dysfunction and coronary microvascular disease in swine

Speaker: Mr J. Hamers (Munich, DE)

Epicardial tissue derived leptin promotes myocardial injury in metabolic syndrome rats through PKC/NADPH oxidase/ROS pathway

Speaker: Doctor H. Chen (Zhengzhou, CN)

Access the full session

Heart failure with preserved ejection fraction: bench

Speakers: Doctor A. Schauer, Doctor C. Panico, Mr J. Hamers, Doctor H. Chen

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources